Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium

Bert Leysen4 sites in 1 country24 target enrollmentOctober 2014

ConditionsPalliative Care Primary Health Care

Overview

Phase: N/A
Intervention: Not specified
Conditions: Palliative Care
Sponsor: Bert Leysen
Enrollment: 24
Locations: 4
Primary Endpoint: percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Registry

clinicaltrials.gov

Start Date

October 2014

End Date

December 2016

Last Updated

8 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Bert Leysen

Responsible Party

Sponsor Investigator

Principal Investigator

Bert Leysen

MD, PhD candidate

Universiteit Antwerpen

Eligibility Criteria

Inclusion Criteria

•identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.

Exclusion Criteria

•not having signed the informed consent.

Outcomes

Primary Outcomes

percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)

Time Frame: 6 months

The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital

Secondary Outcomes

cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)(6 months)
consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)(6 months)
consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)(6 months)
consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)(6 months)